Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE)
United States of America (USA)
1 May 2020 - 1 April 2021
Research collaboration: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE)
Partner Institutions
Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Harvard University, United States of America (USA)
- The University of Chicago (UChicago), United States of America (USA)
- German Cancer Research Center in the Helmholtz Association (DKFZ), Germany
- University of Southern California (USC), United States of America (USA)
- Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA)
- Stanford University, United States of America (USA)
- Vanderbilt University (VU), United States of America (USA)
- The University of Utah (Utah), United States of America (USA)
- NIH National Cancer Institute (NCI), United States of America (USA)
- Genetic Associations and Mechanisms in Oncology (GAME-ON), United States of America (USA)
- University of Cambridge, United Kingdom (UK)
- Queen Mary University of London (QMUL), United Kingdom (UK)
